Food supplement or medicine in Saudi Arabia? The SFDA's classification triggers and the products it has decided

Checked against the SFDA documents named in the Sources on 14 October 2026. This article reports what the regulator has published. It is not legal advice, and the class of your own product is for the SFDA, through your importer or a regulatory adviser, to decide. For the wider question across the EU, Egypt and Lebanon, start with the hub article, does a blister make a supplement a medicine.

When does the SFDA classify a food supplement as a pharmaceutical product?

When any one of five conditions is met. Version 8.0 of the SFDA Products Classification Guidance (20 November 2024) says food supplements will be classified as a pharmaceutical product if a supplement:

1. contains a medicinal herb, or a herb with a medical intended purpose;
2. is at concentrations above the daily limit set by technical standard SFDA.FD 55;
3. is intended "to treat, prevent and/or diagnose a human disease";
4. contains an active medicinal or pharmaceutical ingredient;
5. is not intended for ingestion, such as topicals, inhalers or suppositories.

One condition is enough. A supplement with a plain label and a medicinal herb in the formula is on the pharmaceutical side; a supplement with a harmless formula and a disease statement on the carton is too. That is why a formula and its carton text are checked together, before print.

The guidance sets these out in Note 3, headed "Updates on Food Supplements Regulation". The note names SFDA.FD 55 "Food Supplements" as the standard food supplements must comply with, and refers to SFDA Circular 1337 on updated classification criteria. We have read neither of them, so we give no figures from them.

Which products has the SFDA published as food, and which as medicine?

Appendix 1 of the borderline guidance, "The Illustrative Examples of Borderline Classification Decisions", lists 29 examples across food, cosmetics and medical devices. The table gives eight of the twelve in its drug-food category, the supplement-type ones: five were decided as medicines and three as food. "Medicine" in the table means "regarded under drug regulation", the SFDA's wording. The summary of each decision follows the appendix; the wording of the claims is the SFDA's, not ours.

Read the table by columns three and four. The effervescent tablet, the capsule and the syrup were decided as food, and all three sachets were decided as medicines, each with a claim attached. The same appendix decided a plain psyllium husk powder as food, as dietary fibre without any unacceptable claim, so the same herb sat on both sides of the line, and the claim was the difference. The deciding words are a disease statement (or a claim of protection or improved function that the SFDA read as medical), a medicinal herb, or a level over the limit.

Do vitamins and minerals count as a medicine above a limit?

Yes. Version 8.0 of the guidance lists among the products classified as drugs those with one or more vitamins and minerals "above the upper concentration limit", calculated according to the product's total daily dose. The effervescent vitamin C example in Appendix 1 shows the other side: within the daily allowed limit, it was decided as food.

We give no limit figures here, because the guidance points to SFDA.FD 55 for them and we did not read that standard.

What this costs you is dose room. On the food route, vitamins and minerals are capped per daily dose. A formula above the cap is, on the SFDA's rule, a medicine, which moves it onto a different regulatory path.

Does a claim on the carton, the website or an advert change the class?

Yes, and it is the factor behind three of the five medicine examples above, the three sachets. The borderline guidance names three factors: the intended use and the claims made for the product, on its labelling, websites and promotional or advertising material; its composition and the way it affects the body; and its form. Claims are read wherever they appear: label, website and advertising.

In those three examples the claim was the recorded reason. The practical rule for your artwork follows:

• Write the product name, the contents, the dose and the form on the carton and foil.
• Leave out any statement about a disease, about preventing or treating one, or about helping with a symptom. The guidance accepts health claims on food only when they comply with SFDA.FD 2333 and do not state or imply that the product treats or prevents a disease, so we advise no health claim at all unless your importer has cleared its wording.
• Keep the website and the adverts to the same wording as the carton.

A supplement's pack text is evidence of what the product is for. Customs paperwork is a separate step, described in our article on the Saudi clearance file, and the market overview is on the Middle East page.

Does a tablet, capsule, sachet or effervescent form change the class?

Not on its own. The borderline guidance says "the product format is not always the solely criterion for classification", and that form is reviewed case by case. In Appendix 1, an effervescent tablet, a capsule and a syrup were decided as food, and the sachets were decided as medicines because of what was claimed.

A blister is a pack, not a form. The word "blister" does not appear in the SFDA documents we searched: the Products Classification Guidance (v8.0), the borderline guidance (v3.0) and the pre-registration guide for food products. We searched them on 14 October 2026, and the same search of the NAFDAC, FDA Ghana and Pharmacy and Poisons Board guidelines, described in our article on supplement or medicine in Nigeria, Ghana, Kenya and South Africa, found no match either. The only blister in the SFDA material we read is in a 2007 warning that describes how two products were packed; we come back to it below.

Where the form does matter is the registration file, not the class. For products packed as pills, tablets and capsules, the SFDA's pre-registration guide for food products (a file dated 4 July 2024 in its metadata; the guide carries no version date) lists package leaflets, a GMP certificate "(or equivalent)" under the heading "Pharmaceutical GMP Certificate", the size and shape of the tablet or capsule, a "Product Solubility study" heading, a laboratory safety report and stability studies. For the GMP certificate it adds that an accredited certification body recognised by the Saudi Embassy must issue it. Our plant's GMP is for food supplements, not pharmaceutical GMP, and it is certified as such. Whether a file for tablets or capsules can satisfy that request is for your importer to settle with the SFDA, ideally before you order.

How do I ask the SFDA for a classification before printing?

The borderline guidance says borderline products are classified on an application to the SFDA's Products Classification Department through its electronic system, the ePCS, and gives pcs@sfda.gov.sa for classification requests. We advise asking before the product is printed and shipped, not after. In very difficult cases the department may pass its recommendation to a committee, which the guidance calls the Joint Advisory Committee for Products Classification (JACPC), to decide the regulatory path.

The Products Classification Guidance, version 8.0, states a mandatory submission fee of 1,000 SR and a performance target of 1 working day for the classification service. A decision is valid for one year from approval, and it does not by itself give marketing authorisation. The applicant may appeal within 30 calendar days. Among the documents listed for a request are the product's purpose of use and user instructions, its mechanism of action, its artwork and a quality certificate from the manufacturer. The guidance's list of updates also mentions a relaunch of the PCS system, so confirm the current channel and fee with your importer before you apply.

You cannot be sure of the answer in advance, and that is the point of asking. The answer can be "food", or "medicine", and either one is cheaper to learn before the carton is printed than at the port.

The request is the importer's or the brand owner's step; we do not file it. We can supply the specification and copies of the plant's certificates that a request may draw on.

Documented cases: what did the SFDA and other regulators say about products sold as supplements?

They acted on these products for a short list of reasons, and the form of the pack was not one of them. The table lists the cases we read in the regulators' own notices, and the reason each notice gives. It shows what draws regulator action. It is not a guide to avoiding registration, and nothing in it suggests that any choice of pack, form or wording changes a product's class.

Of the five reasons a buyer might expect (hidden drug substance, disease claim, medicinal herb, dose above the limit, no registration), four appear in the notices above. The fifth, a published case of a dose above the limit, we did not find; that trigger comes from the guidance rule, not from a case. Nor did we find a published case in which a blister turned a food supplement into a medicine.

What a legitimate brand takes from the table is a checklist before print: no undeclared pharmaceutical substance, no medicinal herb unless you intend the pharmaceutical route, doses within the limit, no disease statements, and a registration in place before sale. For the undeclared-substance reason, a buyer can ask us for a test for prohibited substances by a third-party laboratory, on request, with the report in the brand's name.

What does your situation decide?

Each line shows what the choice costs you in time, in route or in risk, not in money.

What do we supply, and what do we not do?

Our work is manufacturing and packing: food supplements for your brand, with tablets, capsules and softgels sealed in blisters and cartoned for your market. Classifying products and filing with the SFDA are not ours, and we do not promise an outcome; the importer or brand owner takes those steps.

What we supply is the documents a file can draw on: a Certificate of Analysis and a specification with each batch, and copies of the plant's certificates, with their numbers, on request. The plant is ISO 22000, GMP and HACCP certified and registered with the US FDA as a food facility. The GMP is for food supplements, not pharmaceutical GMP. Tests for prohibited substances by a third-party laboratory are available on request. Layouts for the carton and foil are in the blister artwork guide, and the batch papers are described on the quality page.

Questions buyers ask about the SFDA and supplement classification

Read more

Does a blister make a supplement a medicine · Supplement or medicine in Nigeria, Ghana, Kenya and South Africa · Saudi clearance file for supplements · The UAE, Saudi Arabia and Lebanon · Tablets in blisters · Capsules in blisters · Export documents · Quality and batch documents